Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis

ConclusionThese findings show substantial alterations in MAS features that may limit utility of defined criteria for diagnosis of systemic JIA patients treated with biologic agents.

Source: Arthritis Care and Research - January 30, 2018 Category: Rheumatology Authors: Grant S. Schulert, Francesca Minoia, John Bohnsack, Randy Q. Cron, Soah Hashad, Isabelle Kon É‐Paut, Mikhail Kostik, Daniel Lovell, Despoina Maritsi, Peter A. Nigrovic, Priyankar Pal, Angelo Ravelli, Masaki Shimizu, Valda Stanevicha, Sebastiaan Vastert Tags: Original Article Source Type: research